标题
Treatment options for alcoholic and non-alcoholic fatty liver disease: A review
作者
关键词
-
出版物
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 23, Issue 36, Pages 6549-6570
出版商
Baishideng Publishing Group Inc.
发表日期
2017-09-25
DOI
10.3748/wjg.v23.i36.6549
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Acetyl-coenzyme A carboxylase inhibition reduces de novo lipogenesis in overweight male subjects: A randomized, double-blind, crossover study
- (2017) Kathryn Stiede et al. HEPATOLOGY
- The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction
- (2017) Philipp Schwabl et al. JOURNAL OF HEPATOLOGY
- Treatment with the natural FXR agonist chenodeoxycholic acid reduces clearance of plasma LDL whilst decreasing circulating PCSK9, lipoprotein(a) and apolipoprotein C-III
- (2017) M. Ghosh Laskar et al. JOURNAL OF INTERNAL MEDICINE
- Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial
- (2017) Tisha R Joy et al. WORLD JOURNAL OF GASTROENTEROLOGY
- BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis
- (2017) Adriana Carino et al. Scientific Reports
- The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans
- (2016) Stefano Ballestri et al. ADVANCES IN THERAPY
- Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design
- (2016) Scott Friedman et al. Contemporary Clinical Trials
- HepaticDPP4DNA Methylation Associates With Fatty Liver
- (2016) Christian Baumeier et al. DIABETES
- Effects of obeticholic acid on lipoprotein metabolism in healthy volunteers
- (2016) R. Pencek et al. DIABETES OBESITY & METABOLISM
- Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease
- (2016) William N. Hannah et al. DIGESTIVE DISEASES AND SCIENCES
- p38 and p38 reprogram liver metabolism by modulating neutrophil infiltration
- (2016) B. Gonzalez-Teran et al. EMBO JOURNAL
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- Hepatic-specific PPARα-FGF21 action in NAFLD
- (2016) Elena Piccinin et al. GUT
- Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD
- (2016) Alexandra Montagner et al. GUT
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis
- (2016) Stefano Ballestri et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis
- (2016) Mei Xiang et al. JOURNAL OF HEPATOLOGY
- Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis
- (2016) Matthew J. Armstrong et al. JOURNAL OF HEPATOLOGY
- Obeticholic acid reduces bacterial translocation and inhibits intestinal inflammation in cirrhotic rats
- (2016) María Úbeda et al. JOURNAL OF HEPATOLOGY
- Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial
- (2016) Jeffrey Cui et al. JOURNAL OF HEPATOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats
- (2016) Geraldine Harriman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Alcoholic liver disease and hepatitis C virus infection
- (2016) Ignacio Novo-Veleiro WORLD JOURNAL OF GASTROENTEROLOGY
- Emerging role of obeticholic acid in the management of nonalcoholic fatty liver disease
- (2016) Evangelia Makri et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV
- (2016) Amedeo Lonardo et al. WORLD JOURNAL OF GASTROENTEROLOGY
- FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis
- (2016) Len Verbeke et al. Scientific Reports
- Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review
- (2016) Amrita Ostawal et al. Diabetes Therapy
- Fibroblast Growth Factor Signaling in Metabolic Regulation
- (2016) Vera J. M. Nies et al. Frontiers in Endocrinology
- Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review
- (2016) Amrita Ostawal et al. Diabetes Therapy
- Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis
- (2016) Eric Lefebvre et al. PLoS One
- An overview of the genetics, mechanisms and management of NAFLD and ALD
- (2015) R. J. Rowell et al. CLINICAL MEDICINE
- Diagnosis and treatment of nutritional deficiencies in alcoholic liver disease: Overview of available evidence and open issues
- (2015) Roberta Elisa Rossi et al. DIGESTIVE AND LIVER DISEASE
- Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis
- (2015) Javier Michelena et al. HEPATOLOGY
- Comparative effectiveness of pharmacological interventions for nonalcoholic steatohepatitis: A systematic review and network meta-analysis
- (2015) Siddharth Singh et al. HEPATOLOGY
- P0932 : Treatment with NGM282 significantly improves liver histopathology in a mouse model of non-alcoholic steatohepatitis (NASH)
- (2015) J. Luo et al. JOURNAL OF HEPATOLOGY
- LP37 : A placebo-controlled, multicenter, double-blind, randomised trial of emricasan in subjects with non-alcoholic fatty liver disease (NAFLD) and raised transaminases
- (2015) M. Shiffman et al. JOURNAL OF HEPATOLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Nutritional therapy in cirrhosis or alcoholic hepatitis: a systematic review and meta-analysis
- (2015) Annette D. Fialla et al. LIVER INTERNATIONAL
- Prednisolone or Pentoxifylline for Alcoholic Hepatitis
- (2015) Mark R. Thursz et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2
- (2015) Christopher Day et al. SEMINARS IN LIVER DISEASE
- Metadoxine improves the three- and six-month survival rates in patients with severe alcoholic hepatitis
- (2015) Fátima Higuera-de la Tijera WORLD JOURNAL OF GASTROENTEROLOGY
- Research Perspectives on the Regulation and Physiological Functions of FGF21 and its Association with NAFLD
- (2015) Takeshi Inagaki Frontiers in Endocrinology
- Systematic review with meta-analysis: the I148M variant of patatin-like phospholipase domain-containing 3 gene (PNPLA3) is significantly associated with alcoholic liver cirrhosis
- (2014) A.-J. Chamorro et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Pharmacotherapy for alcoholic patients with alcoholic liver disease
- (2014) Cynthia L. Vuittonet et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Human lysyl oxidase-like 2
- (2014) Hee-Jung Moon et al. BIOORGANIC CHEMISTRY
- The Fatty Acid–Bile Acid Conjugate Aramchol Reduces Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease
- (2014) Rifaat Safadi et al. Clinical Gastroenterology and Hepatology
- Pharmacological Approaches to Reducing Craving in Patients with Alcohol Use Disorders
- (2014) Carolina L. Haass-Koffler et al. CNS DRUGS
- Knocking on FXR's Door:The "Hammerhead"-Structure Series of FXRs Agonists - Amphiphilic Isoxazoles with Potent In Vitro and In Vivo Activities
- (2014) Christian Gege et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Pentoxifylline for the treatment of nonalcoholic fatty liver disease
- (2014) Tao Zeng et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis
- (2014) Silvia Affò et al. GUT
- Chemokines and alcoholic hepatitis: are chemokines good therapeutic targets?
- (2014) Bin Gao et al. GUT
- Potential role of cytokine CCL20 in alcoholic hepatitis
- (2014) Isobel Leake Nature Reviews Gastroenterology & Hepatology
- TNF and MAP kinase signalling pathways
- (2014) Guadalupe Sabio et al. SEMINARS IN IMMUNOLOGY
- Acute alcoholic hepatitis, end stage alcoholic liver disease and liver transplantation: An Italian position statement
- (2014) Gianni Testino WORLD JOURNAL OF GASTROENTEROLOGY
- Effects of pentoxifylline on nonalcoholic fatty liver disease: A meta-analysis
- (2014) Juan Du WORLD JOURNAL OF GASTROENTEROLOGY
- Management of Alcohol Dependence in Patients with Liver Disease
- (2013) Giovanni Addolorato et al. CNS DRUGS
- Resveratrol modulates autophagy and NF-κB activity in a murine model for treating non-alcoholic fatty liver disease
- (2013) Lake Li et al. FOOD AND CHEMICAL TOXICOLOGY
- Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- (2013) Sunder Mudaliar et al. GASTROENTEROLOGY
- Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis
- (2013) Oriol Morales-Ibanez et al. HEPATOLOGY
- Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2013) Bart Staels et al. HEPATOLOGY
- Association between thePNPLA3(rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant data
- (2013) Eric Trépo et al. HEPATOLOGY
- Prednisolone With vs Without Pentoxifylline and Survival of Patients With Severe Alcoholic Hepatitis
- (2013) Philippe Mathurin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Stem cell therapies for liver failure and cirrhosis
- (2013) Zheng Zhang et al. JOURNAL OF HEPATOLOGY
- Histological improvement following administration of autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study
- (2013) Yoon Ok Jang et al. LIVER INTERNATIONAL
- SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease
- (2013) Yasar Colak et al. MEDICAL SCIENCE MONITOR
- Highest Frequencies of Interleukin-22-Producing T Helper Cells in Alcoholic Hepatitis Patients with a Favourable Short-Term Course
- (2013) Sidsel Støy et al. PLoS One
- Therapy of Experimental NASH and Fibrosis with Galectin Inhibitors
- (2013) Peter G. Traber et al. PLoS One
- Steroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trial
- (2013) Ewan Forrest et al. Trials
- Dietary Omega-3 Fatty Acid Deficiency and High Fructose Intake in the Development of Metabolic Syndrome, Brain Metabolic Abnormalities, and Non-Alcoholic Fatty Liver Disease
- (2013) Artemis Simopoulos Nutrients
- The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology and the American Gastroenterological Association
- (2012) Naga Chalasani et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Mesenchymal-Stem-Cell-Induced Immunoregulation Involves FAS-Ligand-/FAS-Mediated T Cell Apoptosis
- (2012) Kentaro Akiyama et al. Cell Stem Cell
- Comment to “Liver transplantation for patients with alcoholic liver disease: An open question”
- (2012) Gianni Testino et al. DIGESTIVE AND LIVER DISEASE
- Corticosteroid Plus Pentoxifylline Is Not Better than Corticosteroid Alone for Improving Survival in Severe Alcoholic Hepatitis (COPE Trial)
- (2012) Sandeep Singh Sidhu et al. DIGESTIVE DISEASES AND SCIENCES
- Seven sirtuins for seven deadly diseases ofaging
- (2012) Brian J. Morris FREE RADICAL BIOLOGY AND MEDICINE
- Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent
- (2012) Tomonori Aoyama et al. HEPATOLOGY
- Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: New evidence on the potential therapeutic mechanism
- (2012) Claudia O. Zein et al. HEPATOLOGY
- Eukaryotic elongation factor 2 controls TNF-α translation in LPS-induced hepatitis
- (2012) Bárbara González-Terán et al. JOURNAL OF CLINICAL INVESTIGATION
- Malonyl-CoA: the regulator of fatty acid synthesis and oxidation
- (2012) Daniel W. Foster JOURNAL OF CLINICAL INVESTIGATION
- The Evolution and Treatment of Korsakoff's Syndrome
- (2012) A. D. Thomson et al. NEUROPSYCHOLOGY REVIEW
- p38 and p38 kinases regulate the Toll-like receptor 4 (TLR4)-induced cytokine production by controlling ERK1/2 protein kinase pathway activation
- (2012) A. Risco et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Wernicke-Korsakoff-Syndrome: Under-Recognized and Under-Treated
- (2012) Elie Isenberg-Grzeda et al. PSYCHOSOMATICS
- Holotranscobalamin Is a Useful Marker of Vitamin B12 Deficiency in Alcoholics
- (2012) Alberto Fragasso et al. TheScientificWorldJOURNAL
- Nonalcoholic fatty liver disease and bariatric surgery
- (2012) Sindu Stephen et al. Expert Review of Gastroenterology & Hepatology
- Dose-Response Effect of Baclofen in Reducing Daily Alcohol Intake in Alcohol Dependence: Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial
- (2011) G. Addolorato et al. ALCOHOL AND ALCOHOLISM
- Acamprosate for Alcohol Dependence: A Sex-Specific Meta-Analysis Based on Individual Patient Data
- (2011) Barbara J Mason et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Management of Alcoholic Liver Disease: An Update
- (2011) David Kershenobich et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Alcoholic Liver Disease and Malnutrition
- (2011) Craig J. McClain et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- When Galectins Recognize Glycans: From Biochemistry to Physiology and Back Again
- (2011) Santiago Di Lella et al. BIOCHEMISTRY
- FGF21 Analogs of Sustained Action Enabled by Orthogonal Biosynthesis Demonstrate Enhanced Antidiabetic Pharmacology in Rodents
- (2011) J. Mu et al. DIABETES
- Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic Steatohepatitis
- (2011) Michele Malaguarnera et al. DIGESTIVE DISEASES AND SCIENCES
- Protein energy malnutrition predicts complications in liver cirrhosis
- (2011) Ellen J. Huisman et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Sitagliptin as a Novel Treatment Agent for Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus
- (2011) Tomoyuki Iwasaki et al. HEPATO-GASTROENTEROLOGY
- The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91phox mediate hepatic fibrosis in mice
- (2011) Yong-Han Paik et al. HEPATOLOGY
- Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trial
- (2011) Claudia O. Zein et al. HEPATOLOGY
- Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice
- (2011) Alexandre Louvet et al. HEPATOLOGY
- Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease
- (2011) Silvia Sookoian et al. HEPATOLOGY
- Alcoholic liver disease: pathogenesis and new targets for therapy
- (2011) José Altamirano et al. Nature Reviews Gastroenterology & Hepatology
- Early Liver Transplantation for Severe Alcoholic Hepatitis
- (2011) Philippe Mathurin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fish oil improves lipid metabolism and ameliorates inflammation in patients with metabolic syndrome: Impact of nonalcoholic fatty liver disease
- (2011) Mohammed M. H. Al-Gayyar et al. PHARMACEUTICAL BIOLOGY
- Systematic review: glucocorticosteroids for alcoholic hepatitis - a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials
- (2010) A. RAMBALDI et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy
- (2010) R. Galvin et al. EUROPEAN JOURNAL OF NEUROLOGY
- Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data
- (2010) P. Mathurin et al. GUT
- Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: Role of signal transducer and activator of transcription 3
- (2010) Sung Hwan Ki et al. HEPATOLOGY
- A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease
- (2010) Giovanni Musso et al. HEPATOLOGY
- Endocannabinoids in liver disease
- (2010) Joseph Tam et al. HEPATOLOGY
- Prevalence and Trends in Obesity Among US Adults, 1999-2008
- (2010) Katherine M. Flegal JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- An overview of the metabolic effects of rimonabant in randomized controlled trials: potential for other cannabinoid 1 receptor blockers in obesity
- (2010) F. D. Christopoulou et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis
- (2010) Quentin M. Anstee et al. JOURNAL OF HEPATOLOGY
- De novo malignancies following liver transplantation: Impact and recommendations
- (2010) J. Ignacio Herrero LIVER TRANSPLANTATION
- Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment
- (2010) Vivian Barry-Hamilton et al. NATURE MEDICINE
- Serum Dipeptidyl Peptidase-4 Activity in Insulin Resistant Patients with Non-Alcoholic Fatty Liver Disease: A Novel Liver Disease Biomarker
- (2010) Gábor Firneisz et al. PLoS One
- Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis
- (2010) W. Hueber et al. Science Translational Medicine
- cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance
- (2010) Guadalupe Sabio et al. TRENDS IN BIOCHEMICAL SCIENCES
- Understanding and Treating Patients With Alcoholic Cirrhosis: An Update
- (2009) Giovanni Addolorato et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis
- (2009) J. VLACHOGIANNAKOS et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Liver Transplantation for Alcoholic Liver Disease in Europe: A Study from the ELTR (European Liver Transplant Registry)
- (2009) P. Burra et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Infection in Patients With Severe Alcoholic Hepatitis Treated With Steroids: Early Response to Therapy Is the Key Factor
- (2009) Alexandre Louvet et al. GASTROENTEROLOGY
- Hepatic Expression of CXC Chemokines Predicts Portal Hypertension and Survival in Patients With Alcoholic Hepatitis
- (2009) Marlene Dominguez et al. GASTROENTEROLOGY
- Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease
- (2009) Luca Miele et al. HEPATOLOGY
- Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis
- (2009) Rafal P. Witek et al. HEPATOLOGY
- CCR2 promotes hepatic fibrosis in mice
- (2009) Ekihiro Seki et al. HEPATOLOGY
- Alcoholic liver disease
- (2009) Robert S. O'Shea et al. HEPATOLOGY
- The regulation of inflammation by galectin-3
- (2009) Neil C. Henderson et al. IMMUNOLOGICAL REVIEWS
- FGF19-induced Hepatocyte Proliferation Is Mediated through FGFR4 Activation
- (2009) Xinle Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders
- (2009) Jürgen Rehm et al. LANCET
- Role of Muscle c-Jun NH2-Terminal Kinase 1 in Obesity-Induced Insulin Resistance
- (2009) G. Sabio et al. MOLECULAR AND CELLULAR BIOLOGY
- Controversies in the Management of Alcoholic Liver Disease
- (2009) Hui-Hui Tan et al. MOUNT SINAI JOURNAL OF MEDICINE
- Alcoholic Hepatitis
- (2009) Michael R. Lucey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
- (2009) John Willy Haukeland et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Alcoholic Liver Disease and Methionine Metabolism
- (2009) Kusum Kharbanda SEMINARS IN LIVER DISEASE
- Pentoxifylline: A first line treatment option for severe alcoholic hepatitis and hepatorenal syndrome?
- (2009) Stelios F Assimakopoulos et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Pentoxifylline versus prednisolone for severe alcoholic hepatitis: A randomized controlled trial
- (2009) Binay Krishna De et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study
- (2008) Irina A. Kirpich et al. ALCOHOL
- Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis
- (2008) R. LOOMBA et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Alleviation of acute ethanol-induced liver injury and impaired metabolomics of S-containing substances by betaine supplementation
- (2008) Sun J. Kim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Paracrine Activation of Hepatic CB1 Receptors by Stellate Cell-Derived Endocannabinoids Mediates Alcoholic Fatty Liver
- (2008) Won-il Jeong et al. Cell Metabolism
- Osteopontin: Role in immune regulation and stress responses
- (2008) Kathryn X. Wang et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice
- (2008) Shuqin Zheng et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Galectins: structure, function and therapeutic potential
- (2008) Ri-Yao Yang et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Cell Type–Dependent Pro- and Anti-Inflammatory Role of Signal Transducer and Activator of Transcription 3 in Alcoholic Liver Injury
- (2008) Norio Horiguchi et al. GASTROENTEROLOGY
- Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial
- (2008) Vlad Ratziu et al. GASTROENTEROLOGY
- Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
- (2008) Guruprasad P. Aithal et al. GASTROENTEROLOGY
- Stem Cell Therapy for Liver Disease: Parameters Governing the Success of Using Bone Marrow Mesenchymal Stem Cells
- (2008) Tom K. Kuo et al. GASTROENTEROLOGY
- Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo
- (2008) H Aurich et al. GUT
- The interleukin-17 pathway is involved in human alcoholic liver disease
- (2008) Arnaud Lemmers et al. HEPATOLOGY
- Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis
- (2008) Vanessa Stadlbauer et al. JOURNAL OF HEPATOLOGY
- Fructose consumption as a risk factor for non-alcoholic fatty liver disease
- (2008) Xiaosen Ouyang et al. JOURNAL OF HEPATOLOGY
- Health care costs of persons with newly diagnosed hepatitis C virus: a population-based, observational study
- (2008) Thu-Ha Nguyen et al. JOURNAL OF VIRAL HEPATITIS
- Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs
- (2008) Mary Amanda Dew et al. LIVER TRANSPLANTATION
- Endocannabinoids and Liver Disease. I. Endocannabinoids and their receptors in the liver
- (2007) A. Mallat et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More